Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-24-000044
Filing Date
2024-08-06
Accepted
2024-08-06 16:07:29
Documents
83
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q halo-20240630.htm   iXBRL 10-Q 1407340
2 EX-10.1 ex101formofrestrictedunita.htm EX-10.1 70798
3 EX-31.1 ex31110qq22024.htm EX-31.1 12955
4 EX-31.2 ex31210qq22024.htm EX-31.2 12895
5 EX-32 ex3210qq22024.htm EX-32 13879
11 GRAPHIC halo-20240630_g1.jpg GRAPHIC 15840
12 GRAPHIC halo-20240630_g2.jpg GRAPHIC 147351
13 GRAPHIC halo-20240630_g3.jpg GRAPHIC 77244
  Complete submission text file 0001159036-24-000044.txt   8825133

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20240630.xsd EX-101.SCH 48619
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20240630_cal.xml EX-101.CAL 81561
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20240630_def.xml EX-101.DEF 263746
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20240630_lab.xml EX-101.LAB 676300
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20240630_pre.xml EX-101.PRE 471247
86 EXTRACTED XBRL INSTANCE DOCUMENT halo-20240630_htm.xml XML 1295505
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 241179196
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)